Similarly, significantly increased mRNA levels of VCAM-1 were induced by SSc-IgG treatment compared with NC-IgG (P < 0.01; Figure 1D) and reduced by receptor antagonism (ETR-A and ATR-A/ETR-A, each P < 0.05; Figure 1D). This evidence concerns the gene VCAM1 and systemic sclerosis.